Atossa Therapeutics (MEX:ATOS) Other Stockholders Equity: MXN-0.00 Mil (As of Mar. 2026)


MEX:ATOS Atossa Therapeutics Inc MEX:ATOS
28 GF Score
Price MXN32.50
! 2 Warning Signs
View Full Analysis

What is Atossa Therapeutics Other Stockholders Equity?

Atossa Therapeutics MEX:ATOS +4.84% 28 Other Stockholders Equity is MXN-0.00 Mil as of Mar. 2026. GuruFocus rates MEX:ATOS with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Atossa Therapeutics's Other Stockholders Equity for the quarter that ended in Mar. 2026 was MXN-0.00 Mil.

Atossa Therapeutics's quarterly Other Stockholders Equity declined from Sep. 2025 (MXN0.00 Mil) to Dec. 2025 (MXN-0.00 Mil) and declined from Dec. 2025 (MXN-0.00 Mil) to Mar. 2026 (MXN-0.00 Mil).

Atossa Therapeutics's annual Other Stockholders Equity declined from Dec. 2023 (MXN0.00 Mil) to Dec. 2024 (MXN-0.00 Mil) and declined from Dec. 2024 (MXN-0.00 Mil) to Dec. 2025 (MXN-0.00 Mil).

Atossa Therapeutics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Atossa Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atossa Therapeutics Other Stockholders Equity Chart

Atossa Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.00 -0.00 -0.00

Atossa Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.00 -0.00
MEX:ATOS
28GF Score
Atossa Therapeutics Inc MEX:ATOS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atossa Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of MXN-0.00 Mil mean?
Atossa Therapeutics (MEX:ATOS) has a Other Stockholders Equity of MXN-0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Atossa Therapeutics and its competitors.
Is Atossa Therapeutics' Other Stockholders Equity too high?
Atossa Therapeutics' current Other Stockholders Equity is MXN-0.00 Mil. Overall, Atossa Therapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Atossa Therapeutics' Other Stockholders Equity compare to LTRN and ESLA?
Atossa Therapeutics' Other Stockholders Equity of MXN-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Atossa Therapeutics and its competitors. Atossa Therapeutics's current Other Stockholders Equity is MXN-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atossa Therapeutics stock overvalued right now?
Atossa Therapeutics (MEX:ATOS) has a current Other Stockholders Equity of MXN-0.00 Mil. The current Other Stockholders Equity is MXN-0.00 Mil. Atossa Therapeutics' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Atossa Therapeutics (MEX:ATOS), the current Other Stockholders Equity is MXN-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atossa Therapeutics Business Description

Other Exchanges ATOS:USAYAG:Germany
Address 1448 NW Market Street, Suite 500, Seattle, WA, USA, 98107
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
28GF Score

Get the complete analysis for MEX:ATOS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN32.50
Price